MedTrace Logo

A Strategy of Home Telehealth for Management of Congestive Heart Failure(STARTEL)

NCT00247000 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2022-10-31

No results posted yet for this study

Summary

To demonstrate the safety, feasibility, quality of life, primary caregiver satisfaction, and cost effectiveness of integrated Home Telehealth care versus standard care in a heart failure clinic.

Conditions

Interventions

DEVICE

Routine Care in a HF clinic vs Home Telehealth Care for HF

Sponsors & Collaborators

  • Atlantic Health Sciences Corporation

    collaborator OTHER

  • Heart and Stroke Foundation of Canada

    collaborator OTHER

  • Canada Health Infoway

    collaborator OTHER

  • Continuing Care Nova Scotia

    collaborator UNKNOWN

  • Nova Scotia Telehealth Program

    collaborator UNKNOWN

  • AstraZeneca

    collaborator INDUSTRY

  • Nova Scotia Health Authority

    lead OTHER

Principal Investigators

  • Jonathan G Howlett, M.D.,FRCPC · Capital District Health Authority, QEII Health Sciences Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2009-10-31
Completion
2012-10-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00247000 on ClinicalTrials.gov